#227 – How 3 chronic conditions are connected to high blood sugar and what you can do | Dr. Ben Bikman & Dr. Casey Means - (Replay)

From gallbladder issues to tinnitus to fatty liver disease and more, many chronic conditions have links to high blood sugar and insulin resistance. Dr. Ben Bikman and Dr. Casey Means discuss the connections between insulin resistance and ear-nose-and-throat conditions, how insulin resistance increases the risk for gallbladder stones, what non-alcoholic fatty liver disease does to the body, and how you can mitigate these chronic health conditions for improved quality of life. Sign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl Levels helps you see how food affects your health, empowering you with the tools needed to achieve health goals and improve healthspan. Levels Members gain access to the Levels app and continuous glucose monitors (CGMs), providing real-time feedback on how diet and lifestyle choices impact your metabolic health. Look for new shows every month on A Whole New Level, where we have in-depth conversations with thought leaders about metabolic health. 🎙 What Dr. Ben Bikman & Dr. Casey Means discuss: (08:49) - Declining health is not inevitable (10:15) - The link between insulin resistance and tinnitus (13:39) - We look at health through the lens of disease (22:53) - Insulin resistance and the gallbladder (28:32) - The appearance of fatty liver disease (31:34) - Ways to clear the liver of fat (35:00) - How fat tissue develops (36:51) - How fat cells become insulin resistant (46:21) - The power of a CGM (48:36) - What is a healthy glucose level? Transcripts & Show notes 🔗 Helpful links: Watch the conversation: https://youtu.be/szGl8F1zl6I Find us on YouTube: https://youtube.com/levelshealth?sub_confirmation=1 How hearing loss relates to metabolic health | Blog post: https://www.levelshealth.com/blog/how-hearing-loss-relates-to-metabolic-health Why too many focus on glucose, but not insulin | Blog post: https://www.levelshealth.com/blog/why-too-many-focus-on-glucose-but-not-insulin